S. Arikan, Current status of antifungal susceptibility testing methods, Medical Mycology, vol.45, issue.7, pp.569-587, 2007.
DOI : 10.1080/13693780701436794

E. Dannaoui, Comparison of antifungal MICs for yeasts obtained using the EU-CAST method in a reference laboratory and the Etest in nine different hospital laboratories, Clinical Microbiology and Infection, vol.16, issue.7, pp.863-869, 2010.
DOI : 10.1111/j.1469-0691.2009.02997.x

A. Espinel-ingroff, International and Multicenter Comparison of EUCAST and CLSI M27-A2 Broth Microdilution Methods for Testing Susceptibilities of Candida spp. to Fluconazole, Itraconazole, Posaconazole, and Voriconazole, Journal of Clinical Microbiology, vol.43, issue.8, pp.3884-3889, 2005.
DOI : 10.1128/JCM.43.8.3884-3889.2005

M. Fera, L. Camera, E. , D. Sarro, and A. , activity and mechanisms of resistance, Expert Review of Anti-infective Therapy, vol.7, issue.8, pp.981-998, 2009.
DOI : 10.1586/eri.09.67

R. Fleck, A. Dietz, and H. Hof, In vitro susceptibility of Candida species to five antifungal agents in a German university hospital assessed by the reference broth microdilution method and Etest, Journal of Antimicrobial Chemotherapy, vol.59, issue.4, pp.767-771, 2007.
DOI : 10.1093/jac/dkl555

G. Garcia-effron, S. Katiyar, S. Park, T. Edlind, and D. Perlin, A Naturally Occurring Proline-to-Alanine Amino Acid Change in Fks1p in Candida parapsilosis, Candida orthopsilosis, and Candida metapsilosis Accounts for Reduced Echinocandin Susceptibility, Antimicrobial Agents and Chemotherapy, vol.52, issue.7, pp.2305-2312, 2008.
DOI : 10.1128/AAC.00262-08

G. Gonzalez, M. Elizondo, and J. Ayala, Trends in Species Distribution and Susceptibility of Bloodstream Isolates of Candida Collected in Monterrey, Mexico, to Seven Antifungal Agents: Results of a 3-Year (2004 to 2007) Surveillance Study, Journal of Clinical Microbiology, vol.46, issue.9, pp.2902-2905, 2008.
DOI : 10.1128/JCM.00937-08

W. Hope and G. Drusano, Antifungal pharmacokinetics and pharmacodynamics: bridging from the bench to bedside, Clinical Microbiology and Infection, vol.15, issue.7, pp.602-612, 2009.
DOI : 10.1111/j.1469-0691.2009.02913.x

M. Krogh-madsen, M. Arendrup, L. Heslet, and J. Knudsen, Amphotericin B and Caspofungin Resistance in Candida glabrata Isolates Recovered from a Critically Ill Patient, Clinical Infectious Diseases, vol.42, issue.7, pp.938-944, 2006.
DOI : 10.1086/500939

M. Matar, Correlation between E-Test, Disk Diffusion, and Microdilution Methods for Antifungal Susceptibility Testing of Fluconazole and Voriconazole, Antimicrobial Agents and Chemotherapy, vol.47, issue.5, pp.1647-1651, 2003.
DOI : 10.1128/AAC.47.5.1647-1651.2003

E. Mokaddas, N. Sweih, and Z. Khan, Species distribution and antifungal susceptibility of Candida bloodstream isolates in Kuwait: a 10-year study, Journal of Medical Microbiology, vol.56, issue.2, pp.255-259, 2007.
DOI : 10.1099/jmm.0.46817-0

R. Muller and P. Buttner, A critical discussion of intraclass correlation coefficients, Statistics in Medicine, vol.19, issue.23-24, pp.2465-2476, 1994.
DOI : 10.1002/sim.4780132310

L. Ostrosky-zeichner, Antifungal Susceptibility Survey of 2,000 Bloodstream Candida Isolates in the United States, Antimicrobial Agents and Chemotherapy, vol.47, issue.10, pp.3149-3154, 2003.
DOI : 10.1128/AAC.47.10.3149-3154.2003

D. Perlin, Antifungal drug resistance: do molecular methods provide a way forward?, Current Opinion in Infectious Diseases, vol.22, issue.6, pp.568-573, 2009.
DOI : 10.1097/QCO.0b013e3283321ce5

M. Pfaller, Use of Epidemiological Cutoff Values To Examine 9-Year Trends in Susceptibility of Aspergillus Species to the Triazoles, Journal of Clinical Microbiology, vol.49, issue.2, pp.586-590, 2011.
DOI : 10.1128/JCM.02136-10

M. Pfaller, Comparison of European Committee on Antimicrobial Susceptibility Testing (EUCAST) and Etest Methods with the CLSI Broth Microdilution Method for Echinocandin Susceptibility Testing of Candida Species, Journal of Clinical Microbiology, vol.48, issue.5, pp.1592-1599, 2010.
DOI : 10.1128/JCM.02445-09

M. Pfaller, M. Castanheira, S. Messer, G. Moet, and R. Jones, Echinocandin and triazole antifungal susceptibility profiles for Candida spp., Cryptococcus neoformans, and Aspergillus fumigatus: application of new CLSI clinical breakpoints and epidemiologic cutoff values to characterize resistance in the SENTRY Antimicrobial Surveillance Program (2009), Diagnostic Microbiology and Infectious Disease, vol.69, issue.1, pp.45-50, 2009.
DOI : 10.1016/j.diagmicrobio.2010.08.013

M. Pfaller, D. Diekema, and D. Sheehan, Interpretive Breakpoints for Fluconazole and Candida Revisited: a Blueprint for the Future of Antifungal Susceptibility Testing, Clinical Microbiology Reviews, vol.19, issue.2, pp.435-447, 2006.
DOI : 10.1128/CMR.19.2.435-447.2006

M. Pfaller, S. Messer, and A. Bolmstrom, Evaluation of etest for determining in vitro susceptibility of yeast isolates to amphotericin B, Diagnostic Microbiology and Infectious Disease, vol.32, issue.3, pp.223-227, 1998.
DOI : 10.1016/S0732-8893(98)00120-5

M. Pfaller, S. Messer, A. Bolmstrom, F. Odds, and J. Rex, Multisite reproducibility of the Etest MIC method for antifungal susceptibility testing of yeast isolates, J. Clin. Microbiol, vol.34, pp.1691-1693, 1996.

J. Rodriguez-tudela, Statistical Analyses of Correlation between Fluconazole MICs for Candida spp. Assessed by Standard Methods Set Forth by the European Committee on Antimicrobial Susceptibility Testing (E.Dis. 7.1) and CLSI (M27-A2), Journal of Clinical Microbiology, vol.45, issue.1, pp.109-111, 2007.
DOI : 10.1128/JCM.01969-06

D. Sanglard, A. Coste, and S. Ferrari, Antifungal drug resistance mechanisms in fungal pathogens from the perspective of transcriptional gene regulation, FEMS Yeast Research, vol.9, issue.7, pp.1029-1050, 2009.
DOI : 10.1111/j.1567-1364.2009.00578.x